Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes. - Wikidata - awgldk - TriplyDB

Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes.

Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes.

http://www.wikidata.org/entity/Q33697462

about

The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis.

P2860

Q55512530-8682123E-EB1F-44FF-B34E-7C2D06FF61B4

P2860

Study of Neutrophil-lymphocyte Ratio as Novel Marker for Diabetic Nephropathy in Type 2 Diabetes.

http://www.wikidata.org/entity/Q33697462

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Study of Neutrophil-lymphocyte ...... ephropathy in Type 2 Diabetes.

@ast

Study of Neutrophil-lymphocyte ...... ephropathy in Type 2 Diabetes.

@en

type

label

Study of Neutrophil-lymphocyte ...... ephropathy in Type 2 Diabetes.

@ast

Study of Neutrophil-lymphocyte ...... ephropathy in Type 2 Diabetes.

@en

prefLabel

Study of Neutrophil-lymphocyte ...... ephropathy in Type 2 Diabetes.

@ast

Study of Neutrophil-lymphocyte ...... ephropathy in Type 2 Diabetes.

@en

P1433

Q33697462-358C31FC-5C36-4346-931B-DC9DB0D57C51

P1476

Q33697462-17075326-D604-4DFC-AE85-3BD8E9C2D8AA

P2093

Q33697462-2BFF8969-1A2C-4520-9F93-BD325B76396D

Q33697462-94EC25AD-DBD8-4FCB-BD2F-A559C4B666EB

Q33697462-9E5DABD8-DBBC-4796-8129-B478E914F701

Q33697462-C15E5493-3CA8-440D-B00C-576CE7D12079

Q33697462-FB4546D7-C3D3-4248-B85F-8F5B80586DE3

P2860

Q33697462-02DA1F6E-5356-4615-B7C2-A7FDE303A3E0

Q33697462-0B897517-F219-4426-BA45-A8C52715B1EF

Q33697462-35BFB32F-0A0C-4C64-A748-C0B691D2BEE4

Q33697462-48117CA3-152B-4DAB-999C-D0889BE2CCC8

Q33697462-4A8C70BB-2BAD-405F-8256-EE656044F991

Q33697462-51A11F83-A45E-4898-954F-D82EFCAA2910

Q33697462-53709BFE-9F19-4819-8D27-99E3E0512FF9

Q33697462-65559B08-15A8-4121-8423-32E9FF91B1BE

Q33697462-6A3DCB85-0465-4E2A-B167-6C2A4ADDA0C0

Q33697462-6F371AF6-9C3A-4375-B78E-850A45CBF5EF

P304

Q33697462-10B80B34-5728-49CE-ADA4-54E3B2E7AFB4

P31

Q33697462-712A7DBC-1473-4A9F-8D94-7F47BABCA7E0

P356

Q33697462-601C9797-9F79-41AB-807C-03F8D4F42D77

P433

Q33697462-98D2ABB2-60E9-4C39-BA80-61FFEA8DB8DB

P478

Q33697462-BC5A8286-0AE8-49D1-B25B-01AC978CFC64

P577

Q33697462-06D20A15-6A7A-40AD-AE11-D5DE318680DC

P698

Q33697462-29CBAA51-605D-4E99-B2A5-FEA5BBA4CC7F

P921

Q33697462-0910D438-F014-49F8-B8C9-2680574726D1

P932

Q33697462-83A1C915-5690-4F38-8206-C96193E3D686

P356

IJEM.IJEM_476_16

P1433

Indian Journal of Endocrinology and Metabolism

P1476

Study of Neutrophil-lymphocyte ...... ephropathy in Type 2 Diabetes.

@en

P2093

Nitin Nahar

http://www.w3.org/2001/XMLSchema#string

Sachin Chittawar

http://www.w3.org/2001/XMLSchema#string

Sagar Ashokrao Khandare

http://www.w3.org/2001/XMLSchema#string

T N Dubey

http://www.w3.org/2001/XMLSchema#string

Zahraan Qureshi

http://www.w3.org/2001/XMLSchema#string

P2860

End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.

Association of epicardial adipose tissue, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with diabetic nephropathy

Diabetic nephropathy: diagnosis, prevention, and treatment.

Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease.

Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population

Association Between Low-Grade Systemic Inflammation and Type 2 Diabetes Mellitus Among Men and Women from the ATTICA Study.

The relationship between neutrophil-to-lymphocyte ratio and albuminuria in type 2 diabetic patients: a pilot study

In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

How to measure proteinuria?

Pathogenic perspectives for the role of inflammation in diabetic nephropathy.

P304

387-392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/IJEM.IJEM_476_16

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28553592

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

5434720

http://www.w3.org/2001/XMLSchema#string